Nervgen Pharma Corp (NGEN)
Nervgen Pharma Corp (NGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2007 | 06-2007 | 03-2007 | 12-2006 | 09-2006 | |
| Gross Profit | -330 | 5,780 | 4,820 | 5,180 | 3,990 |
| Operating Expenses | 7,230 | 7,540 | 6,510 | 6,630 | 6,240 |
| Operating Income | -7,230 | -7,540 | -6,510 | -6,630 | -6,240 |
| Pre-tax Income | -7,230 | -7,540 | -6,510 | -6,630 | -6,240 |
| Net Income Continuous | -7,230 | -7,540 | -6,510 | -6,630 | -6,240 |
| Net Income | $-7,230 | $-7,540 | $-6,510 | $-6,630 | $-6,240 |
| EBITDA(a) | $-5,480 | $-5,190 | $-4,690 | $-4,880 | $-4,390 |